PRKG1 and hepatocellular carcinoma: Additionally, the AFP enhancer fragment may provide HCC-specific activity to the promoter of the non-tissue-specific, housekeeping phosphoglycerate kinase (pgk) gene, and this novel strategy may be useful for HCC-specific cancer gene therapy [12].